The Food and Drug Administration has approved a new pocket-sized packet option for a testosterone-replacement therapy made by AbbVie, the drug maker said Friday.
Men taking long-acting medications for chronic pain are almost five times more likely to have low testosterone levels, according to a new study by Kaiser Permanente.
The U.S. subsidiary of British drug maker GlaxoSmithKline and U.S.-based Auxilium Pharmaceuticals will co-promote a testosterone-replacement drug, the two said Monday.
The Food and Drug Administration has approved a new formulation of a testosterone therapy made by Watson Pharmaceuticals, the drug maker said Friday.
A topical drug made by Eli Lilly restored testosterone to normal levels in men with abnormally low testosterone, according to results of a late-stage clinical trial.
The Food and Drug Administration has approved a treatment made by Abbott for low testosterone in men, the drug maker said Friday.
Endo Pharmaceuticals has launched a recently approved testosterone gel for men.
Eli Lilly and Australian drug maker Acrux have received approval from the Food and Drug Administration for a testosterone replacement therapy for men, the two companies announced Tuesday.
Endo Pharmaceuticals has resubmitted its application to the Food and Drug Administration for a testosterone...
Eli Lilly & Co. has acquired rights to a testosterone treatment from an Australian manufacturer,...